LNTH · Lantheus Holdings, Inc.
$100.95
+0.01 (+0.01%)
At close · Aug 14
Market Cap
$6.59B
Shares
65.27M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Dr. Ludger Dinkelborg | Head of Research and Development | $15,259,597 |
| Brian Markison | Former Chief Executive Officer | $13,919,738 |
| Paul Blanchfield | Former President | $5,435,275 |
| Robert Marshall | Chief Financial Officer and Treasurer | $5,194,964 |
| Daniel M. Niedzwiecki | Chief Administrative Officer, General Counsel and Corporate Secretary | $4,966,384 |
| Amanda Morgan | Chief Commercial Officer | $3,304,547 |
| Mary Anne Heino | Executive Chairperson and Chief Executive Officer | $2,173,930 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Brian Markison | Chief Executive Officer | $13,400,697 |
| Robert Marshall | Chief Financial Officer and Treasurer | $5,434,796 |
| Paul Blanchfield | President | $5,307,884 |
| Daniel M. Niedzwiecki | Chief Administrative Officer, General Counsel and Corporate Secretary | $4,352,332 |
| Etienne Montagut | Former Chief Business Officer | $3,822,319 |
| Jean-Claude Provost | Chief Science Officer | $3,485,343 |
| Amanda Morgan | Chief Commercial Officer | $2,808,706 |
| Mary Anne Heino | Former Chief Executive Officer | $787,596 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Mary Anne Heino | Former Chief Executive Officer | $12,578,845 |
| Paul Blanchfield | President | $5,305,240 |
| Robert Marshall | Chief Financial Officer and Treasurer | $4,326,011 |
| Daniel M. Niedzwiecki | Chief Administrative Officer, General Counsel and Corporate Secretary | $3,115,728 |
| Jean-Claude Provost | Chief Science Officer | $3,079,307 |
| Etienne Montagut | Former Chief Business Officer | $2,886,791 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Mary Anne Heino | Former Chief Executive Officer | $9,479,445 |
| Robert Marshall | Chief Financial Officer and Treasurer | $3,559,619 |
| Paul Blanchfield | President | $3,408,763 |
| Etienne Montagut | Former Chief Business Officer | $2,510,736 |
| Daniel M. Niedzwiecki | Chief Administrative Officer, General Counsel and Corporate Secretary | $2,393,512 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Mary Anne Heino | Chief Executive Officer | $6,185,143 |
| Robert Marshall | Chief Financial Officer and Treasurer | $2,385,984 |
| Etienne Montagut | Chief Business Officer | $1,684,393 |
| Paul Blanchfield | President Daniel M. Niedzwiecki^(7^^)^ Chief Administrative Officer, General Counsel and Corporate Secretary | $1,575,480 |
| John Bolla | — | $1,438,028 |
| Dr. Istvan Molnar | — | $1,204,151 |
| Daniel M. Niedzwiecki | Senior Vice President, General Counsel and Corporate Secretary | $1,139,696 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Mary Anne Heino | President and Chief Executive Officer | $4,326,357 |
| Robert Marshall | Chief Financial Officer and Treasurer | $1,324,590 |
| Michael P. Duffy | Senior Vice President, Law and Public Policy and General Counsel | $1,097,830 |
| John Bolla | Chief Operations Officer | $1,054,508 |
| Former Chief | Operations Officer | $1,054,508 |
| Dr. Istvan Molnar | Chief Medical Officer | $980,068 |
| Former Chief Medical | Officer | $980,068 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Mary Anne Heino | President & Chief Executive Officer | $4,320,908 |
| Robert Marshall | Chief Financial Officer and Treasurer | $1,435,394 |
| Michael P. Duffy | Senior Vice President, Law and Public Policy and General Counsel | $1,296,700 |
| Cesare Orlandi M.D | Former Chief Medical Officer | $1,064,571 |
| John Bolla | Chief Operations Officer | $1,044,888 |
| Former Chief | Operations Officer | $1,044,888 |
| Simon Robinson Ph.D | Senior Vice President, Research and Pharma Development | $1,010,221 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Mary Anne Heino | President and Chief Executive Officer | $3,913,933 |
| Michael P. Duffy | Senior Vice President, Law and Public Policy and General Counsel | $1,198,257 |
| Cesare Orlandi M.D | Former Chief Medical Officer | $1,133,583 |
| Robert Marshall | Chief Financial Officer | $974,734 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Mary Anne Heino | President and Chief Executive Officer | $3,706,014 |
| Michael P. Duffy | Senior Vice President, Law and Public Policy and General Counsel | $1,209,546 |
| Cesare Orlandi M.D | Former Chief Medical Officer | $1,052,625 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Dr. Phuong Khanh (P.K.) Morrow | Class II director | Appointed | 2026-05-01 |
| Julie McHugh | Class II director | Appointed | 2026-05-01 |
| Heinz Mäusli | Class II director | Appointed | 2026-05-01 |
| Minnie Baylor-Henry | Class II director | Appointed | 2026-05-01 |
| Mary Anne Heino | Interim Chief Executive Officer | Appointed | 2025-11-06 |
| Paul Blanchfield | President | Resigned | 2025-11-06 |
| Mary Anne Heino | Executive Chair | Appointed | 2025-11-06 |
| Brian Markison | member of the Company's board of directors | Resigned | 2025-11-06 |
| Brian Markison | Chief Executive Officer | Retired | 2025-11-06 |
| Phuong Khanh (P.K.) Morrow, M.D. | Class II Director | Appointed | 2025-01-30 |
| Julie Eastland | Class I Director | Appointed | 2024-09-05 |
| Kimberly Brown | principal accounting officer | Appointed | 2024-06-24 |
| Kimberly Brown | Chief Accounting Officer | Appointed | 2024-06-24 |
| Jeffrey S. Humphrey | Chief Medical Officer | Appointed | 2024-05-15 |
| Jean-Claude Provost | Chief Science Officer | Appointed | 2024-05-15 |
| Julie McHugh | Lead Independent Director | Appointed | 2024-01-23 |
| Brian Markison | Executive Chairman | Appointed | 2024-01-23 |
| Brian Markison | Chief Executive Officer | Appointed | 2024-01-23 |
| Mary Anne Heino | Chair of the Board | Appointed | 2024-01-23 |
| Mary Anne Heino | Chief Executive Officer | Retired | 2024-01-23 |
| Julie McHugh | Class II director | Appointed | 2023-05-01 |
| Heinz Mäusli | Class II director | Appointed | 2023-05-01 |
| Minnie Baylor-Henry | Class II director | Appointed | 2023-05-01 |
| Paul Blanchfield | President | Appointed | 2023-03-17 |
| Paul Blanchfield | Chief Operating Officer | Appointed | 2022-06-15 |
Key facts
CIK
1521036
CUSIP
516544103
13F (30d)
426 filings
419 filers
Visit website
Investor relations